{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T12:05:07Z","timestamp":1772366707504,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jcyt.2022.07.013","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T23:35:20Z","timestamp":1661988920000},"page":"1225-1231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4269-7622","authenticated-orcid":false,"given":"Rutvij A.","family":"Khanolkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonam","family":"Dharmani-Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosy","family":"Dabas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2139-5174","authenticated-orcid":false,"given":"Megan","family":"Kinzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Puckrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9294-9437","authenticated-orcid":false,"given":"Victor","family":"Jimenez-Zepeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kareem","family":"Jamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsan","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Storek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jcyt.2022.07.013_bib0001","doi-asserted-by":"crossref","first-page":"e14018","DOI":"10.1111\/ctr.14018","article-title":"Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low-dose total body irradiation, and rabbit antithymocyte globulin","volume":"34","author":"Ousia","year":"2020","journal-title":"Clinical transplantation"},{"issue":"8","key":"10.1016\/j.jcyt.2022.07.013_bib0002","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplantation and cellular therapy"},{"issue":"4","key":"10.1016\/j.jcyt.2022.07.013_bib0003","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/bmt.2008.155","article-title":"Lack of utility of chimerism studies obtained 2\u20133 months after myeloablative hematopoietic cell transplantation for ALL","volume":"42","author":"Doney","year":"2008","journal-title":"Bone marrow transplantation"},{"issue":"3","key":"10.1016\/j.jcyt.2022.07.013_bib0004","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbmt.2008.12.496","article-title":"Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation","volume":"15","author":"Mossallam","year":"2009","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"11","key":"10.1016\/j.jcyt.2022.07.013_bib0005","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3324\/haematol.2009.007765","article-title":"Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation","volume":"94","author":"Bornh\u00e4user","year":"2009","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.jcyt.2022.07.013_bib0006","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bmt.1705582","article-title":"Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia","volume":"39","author":"Huisman","year":"2007","journal-title":"Bone marrow transplantation"},{"issue":"3","key":"10.1016\/j.jcyt.2022.07.013_bib0007","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bmt.1702504","article-title":"Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study","volume":"26","author":"Choi","year":"2000","journal-title":"Bone marrow transplantation"},{"issue":"12","key":"10.1016\/j.jcyt.2022.07.013_bib0008","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/sj.leu.2402311","article-title":"Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation","volume":"15","author":"Mattsson","year":"2001","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.jcyt.2022.07.013_bib0009","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bbmt.2014.04.003","article-title":"Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time","volume":"20","author":"Tang","year":"2014","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"2","key":"10.1016\/j.jcyt.2022.07.013_bib0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41409-021-01518-0","article-title":"Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin","volume":"57","author":"Yeh","year":"2021","journal-title":"Bone Marrow Transplantation"},{"issue":"12","key":"10.1016\/j.jcyt.2022.07.013_bib0011","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jcma.2018.06.005","article-title":"Early achievement of full donor chimerism after allogeneic hematopoietic stem cell transplantation predicts lower relapse risk in patients with acute lymphoblastic leukemia","volume":"81","author":"Chen","year":"2018","journal-title":"Journal of the Chinese Medical Association: JCMA"},{"issue":"2","key":"10.1016\/j.jcyt.2022.07.013_bib0012","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.leu.2401953","article-title":"Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers","volume":"15","author":"Thiede","year":"2001","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.jcyt.2022.07.013_bib0013","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/bmt.2014.254","article-title":"Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia","volume":"50","author":"Jacque","year":"2015","journal-title":"Bone marrow transplantation"},{"issue":"5","key":"10.1016\/j.jcyt.2022.07.013_bib0014","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbmt.2017.01.086","article-title":"Prognostic Limitations of Donor T Cell Chimerism after Myeloablative Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes","volume":"23","author":"Wong","year":"2017","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"11","key":"10.1016\/j.jcyt.2022.07.013_bib0015","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.bbmt.2015.07.005","article-title":"Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes","volume":"21","author":"Lee","year":"2015","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"12","key":"10.1016\/j.jcyt.2022.07.013_bib0016","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.bbmt.2020.07.013","article-title":"Early Mixed Lymphoid Donor\/Host Chimerism is Associated with Improved Transplant Outcome in Patients with Primary or Secondary Myelofibrosis","volume":"26","author":"Deeg","year":"2020","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"10","key":"10.1016\/j.jcyt.2022.07.013_bib0017","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/bmt.2014.158","article-title":"Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCT","volume":"49","author":"Qin","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2022.07.013_bib0018","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3109\/14653249.2012.715243","article-title":"Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation","volume":"14","author":"Bosch","year":"2012","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.jcyt.2022.07.013_bib0019","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"Bacigalupo","year":"2006","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"15","key":"10.1016\/j.jcyt.2022.07.013_bib0020","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/cncr.30540","article-title":"Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trial","volume":"123","author":"Chang","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jcyt.2022.07.013_bib0021","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1470-2045(15)00462-3","article-title":"Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial","volume":"17","author":"Walker","year":"2016","journal-title":"The Lancet Oncology"},{"issue":"29","key":"10.1016\/j.jcyt.2022.07.013_bib0022","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1200\/JCO.20.00150","article-title":"Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study","volume":"38","author":"Chang","year":"2020","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.jcyt.2022.07.013_bib0023","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/S2352-3026(19)30220-0","volume":"7","author":"Walker","year":"2020","journal-title":"The Lancet Haematology"},{"issue":"9","key":"10.1016\/j.jcyt.2022.07.013_bib0024","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/bloodadvances.2018030247","article-title":"Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin","volume":"3","author":"Dabas","year":"2019","journal-title":"Blood advances"},{"issue":"4","key":"10.1016\/j.jcyt.2022.07.013_bib0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bbmt.2009.11.017","article-title":"The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia","volume":"16","author":"Russell","year":"2010","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"9","key":"10.1016\/j.jcyt.2022.07.013_bib0026","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.bbmt.2016.05.020","article-title":"Impact of Donor and Recipient Cytomegalovirus Serostatus on Outcomes of Antithymocyte Globulin-Conditioned Hematopoietic Cell Transplantation","volume":"22","author":"Kalra","year":"2016","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"2","key":"10.1016\/j.jcyt.2022.07.013_bib0027","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/bloodadvances.2016000836","article-title":"Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir\/valacyclovir followed by vaccination","volume":"1","author":"Jamani","year":"2016","journal-title":"Blood advances"},{"issue":"1","key":"10.1016\/j.jcyt.2022.07.013_bib0028","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcyt.2019.11.002","article-title":"High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era","volume":"22","author":"Evernden","year":"2020","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jcyt.2022.07.013_bib0029","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone marrow transplantation"},{"issue":"12","key":"10.1016\/j.jcyt.2022.07.013_bib0030","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"7","key":"10.1016\/j.jcyt.2022.07.013_bib0031","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s41409-020-0876-7","article-title":"Curability and transferability of atopy with allogeneic hematopoietic cell transplantation","volume":"55","author":"Whiteside","year":"2020","journal-title":"Bone marrow transplantation"},{"issue":"3","key":"10.1016\/j.jcyt.2022.07.013_bib0032","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/bmt.2013.191","article-title":"Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial","volume":"49","author":"Wang","year":"2014","journal-title":"Bone marrow transplantation"},{"issue":"2","key":"10.1016\/j.jcyt.2022.07.013_bib0033","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/bmt.2009.151","article-title":"Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants","volume":"45","author":"Bacigalupo","year":"2010","journal-title":"Bone marrow transplantation"},{"issue":"10","key":"10.1016\/j.jcyt.2022.07.013_bib0034","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood.V98.10.2942","article-title":"Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)","volume":"98","author":"Bacigalupo","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jcyt.2022.07.013_bib0035","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jcyt.2021.06.003","article-title":"A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin","volume":"23","author":"Khanolkar","year":"2021","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.jcyt.2022.07.013_bib0036","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.bbmt.2016.01.002","article-title":"Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts","volume":"22","author":"Dabas","year":"2016","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"11","key":"10.1016\/j.jcyt.2022.07.013_bib0037","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jcyt.2019.08.003","article-title":"More acute lymphoid leukemia than acute myeloid leukemia blasts are killed by rabbit antithymocyte globulin","volume":"21","author":"Dabas","year":"2019","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.jcyt.2022.07.013_bib0038","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41409-018-0296-0","article-title":"Anti-thymocyte globulin's activity against acute myeloid leukemia stem cells","volume":"54","author":"Dabas","year":"2019","journal-title":"Bone marrow transplantation"},{"issue":"3","key":"10.1016\/j.jcyt.2022.07.013_bib0039","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12185-014-1510-5","article-title":"Chimerism status is correlated to acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"99","author":"Jiang","year":"2014","journal-title":"International journal of hematology"},{"issue":"1","key":"10.1016\/j.jcyt.2022.07.013_bib0040","first-page":"24","article-title":"The Relationship between STR-PCR Chimerism Analysis and Chronic GvHD Following Hematopoietic Stem Cell Transplantation","volume":"11","author":"Mousavi","year":"2017","journal-title":"International journal of hematology-oncology and stem cell research"},{"issue":"5731","key":"10.1016\/j.jcyt.2022.07.013_bib0041","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/281490a0","article-title":"Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity","volume":"281","author":"Bortin","year":"1979","journal-title":"Nature"},{"issue":"5426","key":"10.1016\/j.jcyt.2022.07.013_bib0042","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.285.5426.412","article-title":"Prevention of graft versus host disease by inactivation of host antigen-presenting cells","volume":"285","author":"Shlomchik","year":"1999","journal-title":"Science (New York, NY)"},{"issue":"5","key":"10.1016\/j.jcyt.2022.07.013_bib0043","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1182\/blood.V99.5.1825","article-title":"Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease","volume":"99","author":"Teshima","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jcyt.2022.07.013_bib0044","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2002-01-0023","article-title":"Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells","volume":"100","author":"Mapara","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2022.07.013_bib0045","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood-2006-03-007427","article-title":"Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions","volume":"108","author":"Chakraverty","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jcyt.2022.07.013_bib0046","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/nm1309","article-title":"A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses","volume":"11","author":"Reddy","year":"2005","journal-title":"Nature medicine"},{"issue":"12","key":"10.1016\/j.jcyt.2022.07.013_bib0047","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.4049\/jimmunol.169.12.7111","article-title":"APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease","volume":"169","author":"Zhang","year":"2002","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"1","key":"10.1016\/j.jcyt.2022.07.013_bib0048","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2006-12-022038","article-title":"The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia","volume":"110","author":"Chakraverty","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jcyt.2022.07.013_bib0049","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.4049\/jimmunol.177.7.4414","article-title":"Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions","volume":"177","author":"Durakovic","year":"2006","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"5","key":"10.1016\/j.jcyt.2022.07.013_bib0050","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nm1038","article-title":"Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease","volume":"10","author":"Merad","year":"2004","journal-title":"Nature medicine"},{"issue":"6","key":"10.1016\/j.jcyt.2022.07.013_bib0051","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/01.tp.0000203318.16224.57","article-title":"Fast appearance of donor dendritic cells in human skin: dynamics of skin and blood dendritic cells after allogeneic hematopoietic cell transplantation","volume":"81","author":"Auffermann-Gretzinger","year":"2006","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.jcyt.2022.07.013_bib0052","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1084\/jem.20060667","article-title":"Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men","volume":"203","author":"Bogunovic","year":"2006","journal-title":"The Journal of experimental medicine"},{"issue":"4","key":"10.1016\/j.jcyt.2022.07.013_bib0053","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood.V99.4.1442","article-title":"Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients","volume":"99","author":"Auffermann-Gretzinger","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jcyt.2022.07.013_bib0054","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.20051787","article-title":"The fate of human Langerhans cells in hematopoietic stem cell transplantation","volume":"203","author":"Collin","year":"2006","journal-title":"The Journal of experimental medicine"},{"issue":"5","key":"10.1016\/j.jcyt.2022.07.013_bib0055","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1182\/blood-2002-02-0419","article-title":"Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants","volume":"100","author":"Billiau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2022.07.013_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.614183","article-title":"Functional Contributions of Antigen Presenting Cells in Chronic Graft-Versus-Host Disease","volume":"12","author":"Hong","year":"2021","journal-title":"Frontiers in immunology"},{"issue":"1","key":"10.1016\/j.jcyt.2022.07.013_bib0057","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/imr.12654","article-title":"TCR repertoire evolution during maintenance of CMV-specific T-cell populations","volume":"283","author":"Schober","year":"2018","journal-title":"Immunological reviews"},{"issue":"5","key":"10.1016\/j.jcyt.2022.07.013_bib0058","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.4049\/jimmunol.179.5.3203","article-title":"Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus","volume":"179","author":"Day","year":"2007","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"1","key":"10.1016\/j.jcyt.2022.07.013_bib0059","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4049\/jimmunol.0803647","article-title":"Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time","volume":"183","author":"Iancu","year":"2009","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"4","key":"10.1016\/j.jcyt.2022.07.013_bib0060","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbmt.2010.07.020","article-title":"Donor serostatus has an impact on cytomegalovirus-specific immunity, cytomegaloviral disease incidence, and survival in seropositive hematopoietic cell transplant recipients","volume":"17","author":"Ugarte-Torres","year":"2011","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"1","key":"10.1016\/j.jcyt.2022.07.013_bib0061","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2003-07-2603","article-title":"Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants","volume":"103","author":"Randolph","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2022.07.013_bib0062","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.tp.0000226156.99206.d1","article-title":"Influence of donor\/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia","volume":"82","author":"Stern","year":"2006","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jcyt.2022.07.013_bib0063","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2003-07-2603","article-title":"Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants","volume":"103","author":"Randolph","year":"2004","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.jcyt.2022.07.013_bib0064","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1182\/blood-2014-11-613323","article-title":"Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans","volume":"125","author":"Nakasone","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jcyt.2022.07.013_bib0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/bbmt.2001.v7.pm11669214","volume":"7","author":"Antin","year":"2001","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"key":"10.1016\/j.jcyt.2022.07.013_bib0066","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-59745-223-6_14","article-title":"Detection of impending graft rejection and relapse by lineage-specific chimerism analysis","volume":"134","author":"Lion","year":"2007","journal-title":"Methods in molecular medicine"},{"issue":"11","key":"10.1016\/j.jcyt.2022.07.013_bib0067","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","article-title":"Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation","volume":"97","author":"Storek","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2022.07.013_bib0068","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41409-021-01515-3","article-title":"Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia","volume":"57","author":"Schmid","year":"2021","journal-title":"Bone Marrow Transplantation"},{"issue":"12","key":"10.1016\/j.jcyt.2022.07.013_bib0069","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.bbmt.2010.06.005","article-title":"Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions","volume":"16","author":"Sairafi","year":"2010","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"15_suppl","key":"10.1016\/j.jcyt.2022.07.013_bib0070","doi-asserted-by":"crossref","first-page":"e19021","DOI":"10.1200\/JCO.2021.39.15_suppl.e19021","article-title":"Outcomes with CD34 stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation for hematologic malignancies: A systemic review and meta-analysis","volume":"39","author":"Shahzad","year":"2021","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1016\/j.jcyt.2022.07.013_bib0071","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/bmt.2013.2","article-title":"CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT","volume":"48","author":"Rosenow","year":"2013","journal-title":"Bone marrow transplantation"},{"key":"10.1016\/j.jcyt.2022.07.013_bib0072","article-title":"Low-Dose Decitabine Monotherapy Reverses Mixed Chimerism in Adult Patients After Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimen: A Pilot Phase II Study","volume":"8","author":"Wang","year":"2021","journal-title":"Frontiers in medicine"},{"issue":"23","key":"10.1016\/j.jcyt.2022.07.013_bib0073","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jcyt.2022.07.013_bib0074","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922007447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922007447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:47:55Z","timestamp":1761443275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324922007447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1465324922007447"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.07.013","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}